We are live on
!
Find out more
IVAV
Index Venture Associates V Portfolio holdings
AUM
$1.46M
1-Year Est. Return
88.05%
This Fund
S&P 500
This Quarter
Est. Return
-35.14%
1 Year Est. Return
-88.05%
3 Year Est. Return
-61.2%
5 Year Est. Return
-86%
10 Year Est. Return
–
AUM
$526M
AUM Growth
-$285M
(-35%)
Cap. Flow
-$27.4K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Minerva Neurosciences
NERV
|
+$27.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 95.57% |
| 2 | Technology | 3.28% |
| 3 | Healthcare | 1.15% |
Similar funds
VM
CL
TGI
HCIG
GAM
MC
NC
NP
Index Venture Associates V's Q4 2018 Portfolio in Review
As of Q4 2018, Index Venture Associates V held 4 positions worth $526M, down 35% from $811M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 0%. Index Venture Associates V opened no new positions and made no exits, leaving the 4-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 96% of assets, up from 95% a quarter earlier, followed by Technology and Healthcare.
- Index Venture Associates V's biggest Q4 2018 reduction was Minerva Neurosciences, cutting an estimated $27.4K.
- Index Venture Associates V's ten largest holdings make up 100% of its $526M portfolio in Q4 2018.
- Index Venture Associates V opened 0 new positions and closed 0 in Q4 2018.
- Index Venture Associates V's portfolio value fell 35% quarter-over-quarter to $526M.
Based on Index Venture Associates V's 13F filing for Q4 2018, filed 12 Feb 2019.